JAK 2 (Janus Kinase 2)
Clinical Significance
The V617F mutation in the JH2 kinase-like domain of JAK 2 is present in most patients with polycythaemia rubra vera, essential thrombocytosis and often in other myeloproliferative disorders.
Method
RT-PCR
Specimen EDTA whole blood (dedicated tube)